Skip to main content
Clinical Trials/CTRI/2024/06/069128
CTRI/2024/06/069128
Not Yet Recruiting
N/A

An observational study to determine haemodynamic stability and renal outcomes in patients undergoing renal transplantation under either Bispectral Index (BIS) monitored Propofol based Total Intravenous Anaesthesia (TIVA) or Minimum Alveolar Concentration (MAC) monitored Sevoflurane based inhalational anaesthesia. - NI

Apollo Multispeciality Hositals Ltd0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Apollo Multispeciality Hositals Ltd
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Apollo Multispeciality Hositals Ltd

Eligibility Criteria

Inclusion Criteria

  • a. Patient visiting the Nephrology and renal Transplant Unit of Apollo Multispeciality Hospitals Limited.
  • b. Patients undergoing renal transplantation.
  • c. Patients from 18 years to 75 years of age group of either sex will be included.
  • d. The patients/patients’ caregivers who will give the written consent to participate in the study.

Exclusion Criteria

  • a. Renal Transplant recipients with Significant Cardiac disease (Ejection Fraction (EF) less than 40 percent)
  • b. Renal disease with a significant potential for recurrence and early kidney graft loss.
  • c. Patients of age less than 18 years and greater than 75 years will be excluded.
  • d. The patients/patients caregivers who will not give the written consent to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials